HEMOSTATIC TREATMENTS FOR ANTICOAGULATED PATIENTS WITH INTRACRANIAL HEMORRHAGE

William David Freeman, MD, Jeffrey I Weitz, MD

Intracranial hemorrhage, which includes various types of bleeding within the skull, poses significant risks for patients undergoing anticoagulant therapy. The document provides an in-depth review of treatment options, focusing on prohemostatic agents that can mitigate bleeding. It also discusses the implications of anticoagulation on patient outcomes, including the potential for increased hematoma growth and neurologic deterioration. The content is regularly updated to reflect new evidence and clinical practices.